Updated: March 2, 2021
An advisory committee for the U.S. Centers for Disease Control and Prevention voted on Saturday to recommend the Pfizer-BioNtech coronavirus vaccine for Americans 16 years and older.
The recommendation came a day after the U.S. Food and Drug Administration (FDA) authorized the vaccine for emergency use.
[read_more id="2" more="Read full article" less="Read less"]
The CDC’s Advisory Committee on Immunization Practices voted in favor of the recommendation with 11 committee members voting for the measure and three recusing themselves.
Vaccines for COVID-19 could be delivered to all healthcare providers in the United States within three weeks, multiple reports quoted Army General Gustave Perna, the chief operation officer for Operation Warp Speed, as saying on Saturday.
Next week, about 3 million doses of Pfizer-BioNtech vaccine will be shipped nationwide.
On Tuesday, an FDA panel will be meeting to review data from the clinical trial of another COVID-19 vaccine developed by Massachusetts-based biotechnology company Moderna.
By the end of December, officials have said as many as 40 million doses of COVID-19 vaccines could be available in the United States.
“I feel confident that as we do the initial shipments this week and then hopefully following with the Moderna vaccine, we will begin to blossom expansion of delivery throughout the states to ensure greater access to the vaccine availability for everybody,” Perna said on Saturday.